Valuation: PolyNovo Limited

Market Cap 61Cr 42Cr 38Cr 35Cr 32Cr 60Cr 3.97TCr 417.74Cr 166.57Cr 2.12TCr 158.7Cr 155.3Cr 6.69TCr P/E 2027 *
63.2x
P/E 2028 * 33.3x
Enterprise Value 57Cr 40Cr 35Cr 32Cr 30Cr 56Cr 3.72TCr 390.53Cr 155.72Cr 1.98TCr 148.36Cr 145.18Cr 6.26TCr EV / Sales 2027 *
3.55x
EV / Sales 2028 * 3.01x
Free-Float
90.03%
Yield 2027 *
-
Yield 2028 * -
1 day-1.66%
1 week-1.66%
Current month-1.66%
1 month-2.20%
3 months+1.71%
6 months-13.17%
Current year-27.64%
1 week 0.86
Extreme 0.857
0.94
1 month 0.84
Extreme 0.84
0.96
Current year 0.81
Extreme 0.81
1.3
1 year 0.81
Extreme 0.81
1.3
3 years 0.81
Extreme 0.81
2.78
5 years 0.81
Extreme 0.81
2.78
10 years 0.17
Extreme 0.17
4.08
Manager TitleAgeSince
Chief Executive Officer - 01/12/2025
Director of Finance/CFO - 12/12/2018
Chief Tech/Sci/R&D Officer - 01/06/2026
Director TitleAgeSince
Chairman - 27/10/2025
Director/Board Member 48 04/06/2021
Director/Board Member 66 14/10/2025
Date Insider Type Main position Quantity % Market Cap. Importance
16/03/26 Buy

Director

1,51,000 0.0219%
27/02/26 Buy

Director

1,00,000 0.0145%
27/02/26 Buy

Chairman

30,000 0.0043%
Change 5-day change 1-year change 3-year change Capi.($)
-1.66%-1.66%-27.05%-32.83% 42Cr
-3.23%+3.51%-12.02%+15.72% 19TCr
-2.90%+5.45%+13.04%+38.65% 12TCr
-2.75%+11.65%-7.90%+17.71% 12TCr
+0.96%+5.15%-38.02%+12.24% 9.93TCr
-1.80%+0.82%-7.41%+69.42% 6.37TCr
-0.78%+7.07%+19.44%-18.22% 5.77TCr
+0.79%+22.65%-5.28%+59.81% 5.33TCr
-6.98%-14.56%-12.60%+42.69% 4.7TCr
-2.36%+3.72%+3.27%-8.07% 3.62TCr
Average -2.07%+4.57%-7.45%+19.71% 7.97TCr
Weighted average by Cap. -2.20%+5.70%-6.95%+24.45%

Financials

2027 *2028 *
Net sales 16Cr 11Cr 9.98Cr 9.12Cr 8.32Cr 16Cr 1.05TCr 109.91Cr 44Cr 557.99Cr 42Cr 41Cr 1.76TCr 19Cr 13Cr 11Cr 10Cr 9.55Cr 18Cr 1.2TCr 126.16Cr 50Cr 640.49Cr 48Cr 47Cr 2.02TCr
Net income 97.73L 67.21L 60.28L 55.09L 50.29L 94.74L 63Cr 6.64Cr 2.65Cr 34Cr 2.52Cr 2.47Cr 106.41Cr 1.85Cr 1.27Cr 1.14Cr 1.04Cr 95.17L 1.79Cr 119.57Cr 13Cr 5.01Cr 64Cr 4.77Cr 4.67Cr 201.41Cr
Net Debt -4.01Cr -2.75Cr -2.47Cr -2.26Cr -2.06Cr -3.88Cr -258.93Cr -27Cr -11Cr -138.16Cr -10Cr -10Cr -436.15Cr -5.53Cr -3.8Cr -3.41Cr -3.12Cr -2.85Cr -5.36Cr -357.63Cr -38Cr -15Cr -190.82Cr -14Cr -14Cr -602.41Cr
Projected Income Statement - Annual - PolyNovo Limited
Logo PolyNovo Limited
PolyNovo Limited is an Australia-based medical technology company. The Company’s business includes designing, manufacturing and selling biomedical devices. Its principal activity is the development of medical devices for medical applications, utilizing the patented bioabsorbable polymer technology NovoSorb. NovoSorb is a family of proprietary medical grade polymers that can be utilized to manufacture medical devices designed to support tissue repair. NovoSorb polymer devices can be expressed in a variety of physical formats including foam, coatings, fibers, plastic structures, films, and biologic carriers. Its products include NovoSorb Biodegradable Temporizing Matrix (BTM) and NovoSorb MTX. NovoSorb BTM is a bilayer dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma or burn. NovoSorb MTX has applicability for single stage grafting in burns, chronic, and surgical wounds.
Employees
301
Date Price Change Volume
06/26/06 A$0.8900 -1.66% 10,62,626
05/26/05 A$0.9050 +3.43% 15,24,680
04/26/04 A$0.8750 -5.41% 9,38,473
03/26/03 A$0.9250 +2.21% 15,08,147
02/26/02 A$0.9050 0.00% 17,82,300
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - PolyNovo Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
0.8900AUD
Average target price
1.254AUD
Spread / Average Target
+40.91%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - PolyNovo Limited